Zdrowie i gospodarka · 14/03/2017

FDA to Host Public Workshop on Generic Drug User Fee Amendments of 2012 and Regulatory Science Initiatives

The Food and Drug Administration (FDA) is hosting a public workshop to gather input from various stakeholders on research priorities for generic drugs, as part of its commitment to develop an annual list of regulatory science initiatives under the Generic Drug User Fee Amendments of 2012 (GDUFA). The workshop will inform the development of the FY 2018 Regulatory Science Plan.